Dudley Robert Michael 13D and 13G filings for TransCode Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-19 5:36 pm Purchase | 2022-10-01 | 13D | TransCode Therapeutics, Inc. RNAZ | Dudley Robert Michael | 67 12.700% | 12 (+22.54%) | Filing |
| 2022-12-19 5:32 pm Purchase | 2021-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | Dudley Robert Michael | 54 10.600% | 54 (New Position) | Filing |